A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma
Ignace B. Vergote, David C. Smith, Raanan Berger, Razelle Kurzrock, Nicholas J. Vogelzang, Avishay Sella, Jennifer Wheler, Yihua Lee, Paul G. Foster, Ron Weitzman, Ronald J. Buckanovich
Research output: Contribution to journal › Article › peer-review
30Scopus
citations
Fingerprint
Dive into the research topics of 'A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma'. Together they form a unique fingerprint.